Depression is officially classified as a medical condition by every major health authority in the world, though the precise label depends on who you ask. The World Health Organization calls it a “depressive disorder,” the American Psychiatric Association uses “major depressive disorder,” and in everyday medical practice, it’s treated as a legitimate diagnosis that appears on insurance claims, disability evaluations, and clinical records. Whether it qualifies as a “disease” in the strictest sense is a surprisingly nuanced question, one that touches on how medicine draws the line between diseases and disorders, and why that distinction matters more than you might expect.
How Depression Is Officially Classified
The two systems that doctors worldwide rely on for diagnosing mental health conditions both recognize depression as a formal medical diagnosis. The WHO’s International Classification of Diseases (ICD-11) uses the term “depressive episode,” while the American Psychiatric Association’s Diagnostic and Statistical Manual (DSM-5) calls it “major depressive disorder.” Both require at least five symptoms from a defined list, and at least one of those must be persistent depressed mood or a marked loss of interest or pleasure in daily activities. These symptoms need to last at least two weeks and cause meaningful disruption to a person’s ability to function.
The WHO estimates that 5.7% of adults globally suffer from depression, making it one of the most common health conditions on the planet. It can be categorized as mild, moderate, or severe based on symptom count and how much it interferes with everyday life. It can also follow different patterns: a single episode that never returns, recurrent episodes over a lifetime, or depressive episodes that alternate with manic episodes in bipolar disorder.
Disease vs. Disorder: Why the Label Matters
You’ll notice that both major diagnostic systems use the word “disorder” rather than “disease.” That’s not an accident. In medicine, a disease typically implies a known underlying biological cause, a specific mechanism you can point to and say, “this is what’s broken.” A disorder, by contrast, is identified by a cluster of symptoms. Clinicians diagnose depression not by finding a particular abnormality on a brain scan or blood test, but by assessing the number and severity of symptoms from an agreed-upon checklist.
This distinction has led some researchers to argue that psychiatric conditions, including depression, are better described as disorders rather than diseases in the strict sense. Most recognized psychiatric disorders are symptom clusters, and there’s no single lab result that confirms or rules out the diagnosis. That said, the word “disorder” doesn’t make depression any less real or medically significant. It simply reflects where our understanding currently stands: we know what depression looks like and how to treat it, even if we can’t yet pin it to one specific biological cause the way we can with, say, diabetes or a bacterial infection.
The Brain Does Change During Depression
Even though depression isn’t diagnosed through imaging, brain scans do reveal measurable physical differences in people who are depressed. MRI studies show reduced brain volume in several regions, with the largest decreases in areas involved in decision-making and emotional regulation. The hippocampus, a region critical for memory and stress response, tends to shrink, particularly in people who have experienced multiple depressive episodes. People who were exposed to abuse or severe stress in childhood show even smaller hippocampal volumes, sometimes before they’ve had a clinical episode of depression.
The amygdala, which processes fear and emotional reactions, becomes hyperactive during depression. The degree of that hyperactivity correlates with how much a person ruminates, experiences intrusive thoughts, or feels anxious alongside their depression. At the cellular level, there’s a decrease in the branching of nerve cells and a deterioration of the connections between them, which slows communication within the brain.
One of the more encouraging findings is that these changes can reverse. In patients who respond well to treatment and achieve remission, hippocampal volume increases compared to those who remain chronically depressed. The brain, in other words, is not permanently damaged by depression. It’s altered in ways that track with the severity and duration of illness, and those alterations can improve.
The “Chemical Imbalance” Theory Is Outdated
If you grew up hearing that depression is caused by low serotonin, you’re not alone. Surveys suggest that over 80% of the general public believes depression results from a chemical imbalance, and many doctors have used this explanation with patients for decades. The idea took hold in the 1990s alongside the rise of SSRI antidepressants, which work by increasing serotonin availability in the brain.
A large systematic review published in Molecular Psychiatry examined the full body of serotonin research and found no consistent evidence that low serotonin activity causes depression. The two largest and most rigorous genetic studies, involving over 150,000 people combined, found no link between the serotonin transporter gene and depression. Studies that artificially lowered serotonin levels in healthy volunteers showed no effect on mood. Some evidence even suggested that long-term antidepressant use may itself reduce serotonin concentration, complicating the picture further.
This doesn’t mean antidepressants don’t work for many people. It means the reason they work is probably more complex than simply “topping off” a low chemical. Researchers have proposed alternative explanations, including the possibility that these medications work partly through emotional blunting, amplified placebo effects, or downstream changes in brain plasticity that have little to do with serotonin specifically.
What Actually Causes Depression
The most accurate framework for understanding depression is the biopsychosocial model, which recognizes three overlapping categories of risk. Biological factors include genetics, brain structure, and neurochemistry. Psychological factors include personality traits, cognitive patterns (like a tendency toward negative thinking), and past trauma. Social factors include isolation, poverty, family conflict, and cultural pressures.
Genetics account for roughly 40 to 50% of depression risk, according to Stanford Medicine, and possibly more for severe forms. But even with identical twins sharing 100% of their DNA, if one twin develops depression, the other develops it only about half the time. That gap is filled by environment and life experience. Someone might carry a strong genetic predisposition but never become depressed if their psychosocial circumstances are favorable. Another person with minimal genetic risk might develop severe depression after prolonged stress, loss, or abuse.
This is part of why the “disease” label feels incomplete to many clinicians. Depression doesn’t behave like a single-cause illness. A person’s personality, their relationships, their financial stability, their childhood experiences, and their biology all feed into the same condition. Medication targeting brain chemistry can produce improvement, but so can therapy that changes thought patterns, or even practical changes that reduce ongoing stress. In some cases, people don’t respond to medication at all until the psychosocial stressors in their life are addressed.
How Classification Affects Insurance and Access
Regardless of whether you call it a disease or a disorder, depression’s inclusion in formal diagnostic systems has real consequences for how people access care. Its classification as a recognized medical condition means health insurance plans are generally required to cover treatment, including therapy and medication. It also means depression can qualify someone for disability accommodations, workplace protections, and medical leave.
Research on insurance and mental health shows that having coverage meaningfully affects outcomes. When people have insurance that covers mental health care, they’re more likely to seek treatment, partly because the financial barrier drops and partly because insurance coverage signals that the condition is “real” and worth treating. Studies of rural populations have found that enrollment in basic medical insurance reduces depression scores, likely through a combination of improved healthcare access and reduced financial stress.
How You Think About It Affects Stigma
The question of whether depression is a disease isn’t just academic. It shapes how people with depression are treated by others and how they see themselves. You might assume that framing depression as a biological disease would reduce stigma, since it implies the person isn’t at fault. The reality is more complicated.
Research published in Scientific Reports found that viewing mental health as a continuum, where everyone falls somewhere on a shared spectrum rather than being neatly divided into “healthy” and “sick,” is more effective at reducing stigma than a strict disease model. People exposed to this continuum framing showed lower levels of negative stereotyping, less prejudice, and greater willingness to interact with someone who has depression. The disease model, by contrast, can inadvertently create a sharp boundary between “normal people” and “patients,” making it easier to see depression as something that happens to a fundamentally different kind of person.
That said, even the continuum approach has limits. The same research found that implicit bias, the automatic, unconscious kind, remained unchanged regardless of how depression was framed. Deep-seated assumptions about mental illness appear resistant to simple reframing, even when people’s conscious attitudes shift.